1.
Emerg Infect Dis
; 10(2): 317-9, 2004 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15030704
RESUMO
A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. Here, we report that recombinant human interferon-beta 1a potently inhibits SARS coronavirus replication in vitro.